Pellicoro A,Ramachandran P,Iredale JP,Fallowfield JA .2014 .Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol, 14(3) : 181-94.
Huang H,Wu T,Mao J,Fang Y,Zhang J,Wu L .2015 .CHI3L1 is a liver-enriched, noninvasive biomarker that can be used to stage and diagnose substantial hepatic fibrosis. OMICS, 19(6) : 339-45.
Kjaergaard AD,Johansen JS,Bojesen SE,Nordestgaard BG .2016 .Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases. Crit Rev Clin Lab Sci, 53(6) : 396-408.
Nøjgaard C,Johansen JS,Christensen E,Skovgaard LT,Price PA,Becker PU .2003 .Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. J Hepatol, 8278(03) : 00184-3.
Sturgeon CM,Sprague S,Almond A,Cavalier E,Fraser WD,Algeciras-Schimnich A .2016 .Perspective and priorities for improvement of parathyroid hormone (PTH) measurement - a view from the IFCC working group for PTH. Clin Chim Acta, 10 : 42.
Ichihara K,Ozarda Y,Barth JH,Klee G,Qiu L,Erasmus R .2016 .A global multicenter study on reference values: 1. Assessment of methods for derivation and comparison of reference intervals. Clin Chim Acta, 09(1) : 70-82.
Jones GR,Koetsier S. .2017 .Uptake of recommended common reference intervals for chemical pathology in Australia. , 54(3) : 395-7.
Horn PS,Pesce AJ .2003 .Reference intervals: an update. Clin Chim Acta, 8981(03) : 00133-5.
Boyd .2010 .cited 2021 Mar]. , : .
Wang L,Liu T,Zhou J,You H,Jia J .2018 .Changes in serum chitinase 3-like 1 levels correlate with changes in liver fibrosis measured by two established quantitative methods in chronic hepatitis B patients following antiviral therapy. Hepatol Res, 48(3) : E283-90.
Horn PS,Pesce AJ .2003 .Reference intervals: an update. Clin Chim Acta, 8981(03) : 00133-5.
Libreros S,Garcia-Areas R,Iragavarapu-Charyulu V .2013 .CHI3L1 plays a role in cancer through enhanced production of proinflammatory/pro-tumorigenic and angiogenic factors. Immunol Res, 57(1-3) : 99-105.
Zhao T,Su Z,Li Y,Zhang X,You Q .2020 .Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduct Target Ther, 5(1) : 201-21.
Kang Q,Chen J,Luo H,Tan N,Gao H,Zhang X .2020 .Decrease in chitinase 3-like protein 1 levels reflects improvement in liver fibrosis after HCV eradication. Dis Markers, : 9.
Berres ML,Papen S,Pauels K,Schmitz P,Zaldivar MM,Hellerbrand C .2008 .A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection. J Hepatol, 09(2) : 370-6.
Yan C,Hu J,Yang J,Chen Z,Li H,Wei L .2018 .Serum ARCHITECT PIVKA-II reference interval in healthy Chinese adults: sub-analysis from a prospective multicenter study. Clin Biochem, 02 : 32-6.
Katayev A,Balciza C,Seccombe DW .2010 .Establishing reference intervals for clinical laboratory test results: is there a better way?. Am J Clin Pathol, 133(2) : 180-6.
Saleh AA,Alhanafy AM,Elbahr O,El-Hefnawy SM .2020 .Chitinase 3-like 1 gene (T/C) polymorphism and serum YKL-40 levels in patients with hepatocellular carcinoma. Meta Gene, 24(1) : 100686.
Mushtaq S,Ghani E,Azam K,Hussain T,Kumagai E,Mano Y,Yoshio S,Shoji H,Sugiyama M,Korenaga M .2016 .Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease. Sci Rep, 6(3) : 35282-92.